Literature DB >> 32378315

Use of face masks in dermatology department during the COVID-19 outbreak.

Mohamad Goldust1, George Kroumpouzos2,3, Dedee F Murrell4, Mohammad Jafferany5, Torello Lotti6, Uwe Wollina7, Swathi Shivakumar8.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32378315      PMCID: PMC7267171          DOI: 10.1111/dth.13521

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   3.858


× No keyword cloud information.
Dear Editor, The novel corona virus disease 2019 (COVID‐19), which began in Wuhan, China in late December 2019, has quickly spread throughout the world to reach pandemic proportions. The main reason for this is due to its high contagiousness, being present in respiratory droplets even in the initial incubation period (up to 14 days). , , Therefore, a presumed to be healthy person may be harboring the virus and spreading it to others even prior to onset of symptoms. This highlights the need to use personal protective equipment (PPE) and practice social distancing in order to control the alarming spread. , In most countries, a complete lockdown was ordered by government authorities, keeping open only essential services like hospitals, pharmacies, groceries, and automated teller machines. It is still a moral dilemma whether nonemergency services like Dermatology should remain open. However, there are also emergencies in Dermatology Clinics. If kept open, utmost care needs to be taken so that we do not become vectors in the spread of this virus. Current guidelines by World Health Organization (WHO) advice against community use of masks due to lack of evidence as well as gross shortage of masks. However, global use of masks may be the only way of control of spread of infection from asymptomatic carriers. Most health care providers agree that wearing a self‐made mask, or even a scarf covering the face and eye glasses, is better than not wearing any. It is especially necessary in a setting like dermatology outpatients where the number of cases is bigger and chances of cross‐infection from physician to patient, or vice versa, are high. The outpatient case load can be reduced by limiting appointments to only emergency cases. Routine follow‐up visits can be converted into virtual visits (teledermatology). All patients should be screened for symptoms of fever, cough, and sore throat, and referred to Fever Clinic or Infectious Disease specialist, if symptomatic. The remaining patients should be educated on maintaining social distance, observing hand hygiene, and should be provided with surgical masks prior to an encounter. They should be advised to never take off the mask during the consult, except in instances where the physician needs to examine facial lesions. Doctors and nursing staff should be well protected with PPE, including masks, surgical caps, protective suits, and goggles. Surgical masks are to be worn by health care personnel at all times during a patient encounter. Their PPE should be taken off only at the end of their work hours, in a designated disposable area. Measures to face the increased demand for masks include mass production and stockpiling, as was done successfully in Taiwan. As a response to the shortage of facemasks, posts of self‐made masks, made of different materials, including a plastic transparent sheet that covers the eyes, have appeared in social media. Urgent research is needed to prolong the use of disposable masks and for invention of reusable masks. A recent protocol was developed by researchers at Duke University where N95 masks could be resterilized. This could prove very valuable to help relieve the current global shortage of masks.

CONFLICT OF INTEREST

The authors declare no potential conflict of interest.

DISCLAIMER

We confirm that this article has been read and approved by all the authors, that the requirements for authorship as stated earlier in this article have been met and that each author believes that this article represents honest work.
  9 in total

1.  COVID-19-New Insights on a Rapidly Changing Epidemic.

Authors:  Carlos Del Rio; Preeti N Malani
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  Mass masking in the COVID-19 epidemic: people need guidance.

Authors:  Chi Chiu Leung; Tai Hing Lam; Kar Keung Cheng
Journal:  Lancet       Date:  2020-03-03       Impact factor: 79.321

3.  COVID-19 and SARS: Differences and similarities.

Authors:  Antonio Caldaria; Claudio Conforti; Nicola Di Meo; Caterina Dianzani; Mohammad Jafferany; Torello Lotti; Iris Zalaudek; Roberta Giuffrida
Journal:  Dermatol Ther       Date:  2020-04-30       Impact factor: 2.851

4.  The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments.

Authors:  Aseem Sharma; Regina Fölster-Holst; Martin Kassir; Jacek Szepietowski; Mohammad Jafferany; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-25       Impact factor: 2.851

5.  Priorities for global health community in COVID-19 pandemic.

Authors:  Lidia Rudnicka; Mrinal Gupta; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-08       Impact factor: 2.851

6.  Solidarity and transparency against the COVID-19 pandemic.

Authors:  Gulhima Arora; George Kroumpouzos; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Zuzanna Sitkowska; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-13       Impact factor: 2.851

7.  Rational use of face masks in the COVID-19 pandemic.

Authors:  Shuo Feng; Chen Shen; Nan Xia; Wei Song; Mengzhen Fan; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2020-03-20       Impact factor: 30.700

8.  What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?

Authors:  Yusha Chen; Sushmita Pradhan; Siliang Xue
Journal:  J Am Acad Dermatol       Date:  2020-02-17       Impact factor: 11.527

9.  Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits.

Authors:  Shawn G Kwatra; Ronald J Sweren; Anna L Grossberg
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  9 in total
  3 in total

1.  Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.

Authors:  Shahram Seyfi; Robabeh Alijanpour; Zeinab Aryanian; Khadijeh Ezoji; Mahdi Mahmoudi
Journal:  J Med Life       Date:  2022-05

Review 2.  Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.

Authors:  Rachel K Lim; Saisanjana Kalagara; Kenneth K Chen; Eleftherios Mylonakis; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2021-08-26

3.  Impact of COVID-19 pandemic on dermatology practices: Results of a web-based, global survey.

Authors:  Shashank Bhargava; Charles McKeever; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2020-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.